Crossmark

Treating nonischaemic stable CAD lesions—safe to DEFER?

Crossref DOI link: https://doi.org/10.1038/nrcardio.2015.173

Published Online: 2015-11-19

Published Print: 2016-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Koskinas, Konstantinos C.

Windecker, Stephan
License Information

Text and Data Mining valid from 2015-11-19
More Information

Article History

First Online: 19 November 2015

Competing interests

: S.W. declares that he has received institutional research grants from Abbott, Biotronik, Boston Scientific, Edwards, Medtronic, and St. Jude Medical, and that he has received speaker fees from Abbott, Astra Zeneca, Bayer, Biosensors, Biotronik, Boston Scientific, Edwards, and Medtronic. K.C.K. declares no competing interests.